Benefits of Hormone Replacement Therapy · Relieve menopausal symptoms · Prevent osteoporosis · Maintain muscle strength. If you're younger than 60, have menopausal symptoms, and aren't at high risk of breast cancer or blood clots, the benefits of hormone therapy are likely to outweigh the risks. Previously, hormone therapy was used routinely to treat menopausal symptoms and protect long-term health. Then, large scale clinical trials showed health risks. What does this mean for you? Menopause is a stage in life when the ovaries stop producing the hormones estrogen and progesterone and menstrual periods stop.
Anyone with ovaries can experience menopause, including women and trans, non-binary, and gender-diverse people. This usually occurs between the ages of 45 and 55, but it can vary. Some people may enter menopause prematurely as a side effect of medical treatment, such as chemotherapy or removal of the ovaries. Menopause symptoms include hot flashes, mood changes, and trouble sleeping, but everyone's experience is different.
Some people may not be bothered by symptoms, while others may find it difficult to cope with them. Treatment options are available to help alleviate symptoms. Hormone replacement therapy (HRT) is an effective way to reduce menopausal symptoms and improve the quality of life for people experiencing menopause. Some studies show that hormonal hormone therapy may increase the risk of breast and ovarian cancer, while other studies show no increased risk.
If you are considering taking hormone therapy, the Canadian Cancer Society recommends that you talk to your healthcare provider about how hormone therapy can alleviate menopausal symptoms and about your individual risks. Low-dose hormone therapy may slightly increase the risk of breast and ovarian cancer, but this risk can be kept low if used for the shortest time possible. Combined HRT (estrogen and progestin) is associated with a small increase in the risk of breast and ovarian cancer. This risk may be influenced by individual factors, how long a person receives hormone replacement therapy and the time between the start of menopause and the start of hormone therapy.
Some studies suggest that people who take combined or estrogen-only hormone replacement therapy may have a lower risk of colorectal cancer, while other studies don't indicate this. HRT is not recommended to prevent colorectal cancer. Some hormone products, which may be referred to as bioidentical hormones, are available without a prescription. Bioidentical hormones are made from plant sources and are basically the same as the hormones our bodies produce.
You may have heard claims that these products are more natural, effective, and safe than hormonal hormone therapy, but there's no scientific evidence to prove this. Not all alternatives to hormone therapy have been tried to evaluate side effects. Hormone replacement therapy may still be useful in relieving menopausal symptoms in the short term if other treatments don't work and the symptoms are severe. Hormone replacement therapy is a type of treatment that helps restore the hormones estrogen and progesterone during perimenopause and menopause. Hormone replacement therapy is a medication that contains hormones that the ovaries produce less of as women age and reach menopause.
The benefits and risks of hormone therapy depend on your age, menopausal symptoms, and any risk factors that TENGA. The development of a substantial risk of CVD after menopause provides an opportunity to extend cardioprotection against endogenous estrogen in postmenopausal women using hormone replacement therapy (HRT) as a primary, sex-specific preventive therapy for CVD and to reduce all-cause mortality. According to the hypothesis, estrogen exerts early beneficial effects of hormonal therapy on healthy endothelium, but it has adverse effects on established plaques (fig. In addition to confirming the timing hypothesis, ELITE provides a pathophysiological mechanism by which HRT reduces CVD by reducing the progression of atherosclerosis, the main underlying pathogenesis of CVD (. The meta-analyses were validated and confirmed by the Cochrane group, which also showed similar reductions in all-cause mortality (30%; 95% CI, 5-48%) and in coronary heart disease (48%; 95% CI, 4% — 71%) in women who started therapy hormonal.
These latter women represent the typical woman who begins hormone replacement therapy when she is younger and is close to menopause. Importantly, these cumulative data showed that, when analyzing the effect of HRT on all-cause mortality and coronary heart disease in all women, regardless of the time elapsed since menopause and at all ages combined, the results were null, hiding the beneficial effect of HRT on all-cause mortality and CHD in women who started HRT at a younger age, close to menopause. Not all alternatives to hormone replacement therapy have been scientifically proven, but many people find them useful. Meta-analyses of cumulative data from RCTs show that hormonal hormone therapy significantly reduces all-cause mortality.
and cardiovascular diseases when it starts in women. You can lower your risk of breast cancer if you don't take hormone therapy for longer than necessary to control symptoms. More research is being done to find out how hormone replacement therapy affects other conditions, such as dementia and diabetes. The meta-analyses are consistent with the estimates of observational studies conducted in populations of younger women who started hormone therapy at or near the time of menopause.
(18.1).
